Kopran Ltd share price logo

Kopran Share Price (KOPRAN)

₹156.711.19%

as on

| Source : NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Kopran Stock Performance

as on August 26, 2025 at 4:01 PM IST

  • Day's Low

    Day's High

    ₹156
    ₹161.75
    downward going graph

    0.45%

    Downside

    3.22%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹155
    ₹369.7
    downward going graph

    1.09%

    Downside

    135.91%

    Upside

    downward going graph
Previous Close₹158.60
Open₹158.10
Volume97.22K
Upper Circuit₹190.32
Lower Circuit₹126.88
Day's Low156
Day's High161.75
52 Week Low155
52 Week High369.7
1 Month Return-11.6 %
3 Month Return-15.31 %
1 Year Return-49.76 %
3 Year Return-15.25 %
5 Year Return+ 113.79 %

Kopran Stock Fundamentals & Key Indicators

Check Kopran market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹756.68 Cr

Return on Equity (ROE)

6.33

PE Ratio (TTM)

21.65

Return on capital employed (ROCE)

8.54

Industry PE ratio

43.96

Beta (LTM)

1.42

P/B Ratio

1.96

Dividend Yield

0

PEG Ratio

-4.28

Quarterly Earnings Growth YOY

-32.88

EPS (TTM)

7.98

Sector

Pharmaceuticals

Book Value

107.35

Technical Analysis

Kopran Stock's Interest Amongst Investors

-21%

Period Aug 27, 2025 to Jul 28, 2025. Change in 30 Days vs previous period

Search interest for Kopran Ltd Stock has decreased by -21% in the last 30 days, reflecting a downward trend in search activity.

Kopran Stock Valuation

Track how Kopran P/E has moved over time to understand its valuation trends.

Kopran in the last 5 years

  • Overview

  • Trends

Lowest (3.00x)

March 24, 2020

Today (21.65x)

August 26, 2025

Industry (43.96x)

August 26, 2025

Highest (53.33x)

September 5, 2023

LowHigh

Today’s Price to Earnings Ratio: 21.65x

Kopran Ltd Financial Results

Get the annual and quarterly financial summary of Kopran Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26
Revenue

(in ₹ Cr)

139 (0%)152 (9%)166 (10%)172 (4%)135 (22%)
Net Income

(in ₹ Cr)

11 (0%)7 (34%)10 (41%)10 (7%)7 (23%)
Net Profit Margin7.96% (0%)4.87% (39%)6.26% (29%)5.62% (10%)5.51% (2%)
Value in ₹ crore
DetailsFY22FY23FY24FY25
Total Assets

(in ₹ Cr)

613 (0%)652 (6%)746 (14%)847 (14%)
Total Liabilities

(in ₹ Cr)

187 (0%)213 (14%)255 (20%)329 (29%)
Value in ₹ crore
DetailsFY21FY22FY23FY24FY25
Operating Cash Flow

(in ₹ Cr)

49 (0%)-38 (178%)17 (145%)35 (107%)23 (33%)

Kopran Earnings and Dividends

View detailed summary of the earnings and dividend history of Kopran.

  • Kopran Ltd Earnings Results

    Kopran Ltd’s net profit fell -32.88% since last year same period to ₹7.45Cr in the Q1 2025-2026. On a quarterly growth basis, Kopran Ltd has generated -23.04% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Kopran Ltd Dividends May,2024

    In the quarter ending March 2024, Kopran Ltd has declared dividend of ₹3.00 per share on 16 May 2024 - translating a dividend yield of 3.78%.

    Read More about Dividends

Indices Featuring Kopran Stock

Check stock indices that include Kopran.

BSE Healthcare

₹44,075.94

-1.65 (-739.95%)

BSE Small-Cap

₹52,097.59

-1.68 (-891.75%)

Kopran Stock Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Kopran.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
44.42%
0.00
Foreign Institutions
0.76%
-32.56
Mutual Funds
0%
0.00
Retail Investors
54.82%
0.67
Others
0%
3.45

Kopran Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Kopran with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA756.6822.76%0.6238629
NA45.57-8.65%0.001124
BUY27,831.201.61%0.637077,896
NA1,185.33-9.63%0.6457398
NA41.995.88%0.001221

Kopran News & Key Events

Latest news and events in one place to help you make informed investing decisions in Kopran.

  • Viraj Mehta Sells Stake in Kopran, Shares Drop - 23 Jun, 2025

    Viraj Russell Mehta sold 4 lakh shares of Kopran for Rs 7 crore, reducing his stake from 1.85% to 1.03%. Following the sale, Kopran's shares fell by 5.52% to Rs 176.57.

Insights on Kopran Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 54.45% to 54.82% in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 133.9% return, outperforming this stock by 149.1%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 44.42% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 26.3% return, outperforming this stock by 76.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, KOPRAN stock has moved down by -49.8%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 175.62 Cr → 137.77 Cr (in ₹), with an average decrease of 21.6% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 1.12% to 0.76% in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 10.4 Cr → 7.45 Cr (in ₹), with an average decrease of 15.0% per quarter

About Kopran Ltd

Kopran, a pharmaceutical company controlled by Parijat Enterprises and promoted by Somani group, came out with a public issue in Nov.92 to finance its backward integration project and expand its antibiotic facility. Its bulk drug plant is approved by the US FDA and UK regulatory authorities, and in 1995 they were awarded Quality Excellence award by Indian Drug Manufacturers Association. Kopran manufactures penicillin and amoxycillin and has collaborations with Germany, South Korea, US and Adac Laboratories.They launched new products for therapeutic groups like asthma, cardiology, diabetes and lifestyle and obtained approval from European Directorate for Quality of Medicines and UK MHRA. Furthermore, they increased their installed capacity of liquids by 3.00 lakhs of liters and tablets/capsules by 270 croresNos during 2001. They also had tied up with EMerck for comarketing a new antiinflammatory drug in India and subsequently launched Cholestat Atorvastatin. Kopran has a high growth rate in exports and has been ranked amongst the top few fastest growing companies in IndiaORG Marg June 2000.

Revenue: ₹135.22Cr as on June 2025 (Q1 FY26)
Net Profit: ₹7.45Cr as on June 2025 (Q1 FY26)
Listing date: 01 Dec, 1994
Chairperson Name: Susheel Somani
OrganisationKopran Ltd
IndustryPharmaceuticals
CEOSusheel Somani
E-voting on sharesClick here to vote

Mutual Funds that own Kopran Stock

Check out the Mutual Funds with significant holdings in Kopran.

FAQs

What is Kopran share price today?

Kopran share price today stands at ₹156.71, Open: ₹158.1, Previous Close: ₹158.6, High: ₹161.75, Low: ₹156, 52 Week High: ₹369.7, 52 Week Low: ₹155 as on .

How to buy Kopran shares ?

To buy Kopran shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for KOPRAN or Kopran Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Kopran shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is today's traded volume of Kopran?

Today's traded volume of Kopran is 97.22K. Which means that 97.22K shares of Kopran were bought and sold on the stock market during today's trading session.

What is Kopran's market cap today?

Today's market capitalisation of Kopran is ₹756.68 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Kopran?

Kopran’s 52 week high is ₹369.7 and 52 week low is ₹155. The current share price of Kopran is ₹156.71, which is -57.61% down from its 52 week high and 1.10% up from its 52 week low.